Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4647 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.53 USD | 0.00% | -0.78% | +2.02% | +20.48% | 11.19 M USD | ||
| 4650 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.94 USD | -4.08% | +17.50% | +10.59% | -58.22% | 11.12 M USD | ||
| 4651 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.25 USD | 0.00% | -13.79% | +4.17% | -51.92% | 11.09 M USD | ||
| 4653 |  TOVX Theriva Biologics, Inc. Common Stock | 0.24 USD | -4.00% | +4.35% | -4.00% | -4.00% | 11.01 M USD | ||
| 4659 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.20 USD | +2.56% | -19.46% | -37.50% | -49.37% | 10.81 M USD | ||
| 4661 |  GTBP GT Biopharma, Inc. - Common Stock | 5.95 USD | -4.03% | -6.45% | -2.94% | +682.89% | 10.74 M USD | ||
| 4664 |  LTRN Lantern Pharma Inc. - Common Stock | 0.83 USD | -8.79% | -18.63% | -52.02% | -80.19% | 10.61 M USD | ||
| 4668 |  ADIL Adial Pharmaceuticals, Inc - Common Stock | 3.97 USD | -0.50% | -12.17% | -33.16% | +845.24% | 10.42 M USD | ||
| 4679 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.39 USD | +2.21% | +6.92% | -47.94% | -6.08% | 10.00 M USD | ||
| 4681 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.32 USD | -3.03% | +3.23% | 0.00% | -66.32% | 9.97 M USD | ||
| 4693 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.22 USD | +0.45% | -4.72% | -12.25% | -21.00% | 9.66 M USD | ||
| 4695 |  BIVI BioVie Inc. - Common stock | 1.28 USD | -8.57% | -12.93% | -34.36% | +1.59% | 9.65 M USD | ||
| 4704 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.46 USD | +6.98% | +12.20% | -4.17% | +21.05% | 8.95 M USD | ||
| 4705 |  QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 4.55 USD | -3.19% | -5.41% | -33.48% | -51.18% | 9.14 M USD | ||
| 4708 |  IMRN Immuron Limited - American Depositary Shares | 1.11 USD | +1.83% | -0.89% | -35.47% | -47.64% | 8.96 M USD | ||
| 4711 |  MTVA MetaVia Inc. - Common Stock | 1.34 USD | -8.22% | -14.10% | -23.43% | +28.85% | 8.83 M USD | ||
| 4735 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.42 USD | -4.55% | -17.65% | -46.84% | -86.67% | 8.18 M USD | ||
| 4741 |  AZTR Azitra Inc Common Stock | 0.13 USD | 0.00% | 0.00% | -27.78% | -18.75% | 7.88 M USD | ||
| 4744 |  CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.35 USD | -1.47% | +2.29% | -7.60% | -45.80% | 7.82 M USD | ||
| 4751 |  SNGX Soligenix, Inc. - Common Stock | 0.35 USD | 0.00% | -5.41% | -2.78% | -69.03% | 7.62 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |